BIGG

Resultados: 9

Guideline No. 449: Diagnosis and Impact of Endometriosis – A Canadian Guideline

J. obstet. gynaecol. Can; 46 (5), 2024
To provide a contemporary approach to the understanding of the impact and methods for the diagnosis of endometriosis in Canada. Individuals, families, communities, health care providers, and health care administrators who are affected by, care for patients with, or manage delivery of services for endomet...

Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines)

Hepatol. res; 53 (5), 2023
The fifth version of the Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence-based medicine and partly to the Grading of Recommendations Assessment, Development and Evaluation system, which was published in Oct...

Gliomy mozku: diagnostika a léčba
Brain gliomas: diagnosis and treatment

Ačkoliv se v případě gliomů jedná o vzácná onemocnění, představují celospolečenský problém z několika důvodů. Nejčastějším a zároveň nejagresivnějším gliomem je glioblastom, infiltrativně rostoucí nádor s časnými recidivami navzdory kombinované trimodalitní standardní l...

Guideline No. 408: management of gestational trophoblastic diseases

J. obstet. gynaecol. Can; 43 (1), 2021
This guideline reviews the clinical evaluation and management of gestational trophoblastic diseases, including surgical and medical management of benign, premalignant, and malignant entities. The objective of this guideline is to assist health care providers in promptly diagnosing gestational trophoblast...

Colorectal cancer

This guideline covers managing colorectal (bowel) cancer in people aged 18 and over. It aims to improve quality of life and survival for adults with colorectal cancer through management of local disease and management of secondary tumours (metastatic disease)....

Biomarcadores en las neoplasias mieloproliferativas clásicas BCR-ABL1 negativas
Biomarkers in Classical Myeloproliferative Neoplasms BCR-ABL1 negative

Introducción: Los biomarcadores son útiles en la definición del diagnóstico, pronóstico y seguimiento de múltiples enfermedades. La detección o medición de uno o más biomarcadores específicos representan alteraciones en vías genéticas o epigenéticas que controlan la proliferación, diferenci...

European evidence-based guidelines on pancreatic cystic neoplasms

Gut; 67 (5), 2018
Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of the Pancreas, United European Gastroenterology, European Pancreatic Club, European-African Hepato-Pancreato-Biliary Associati...

Guía de práctica clínica para la tamización del cáncer colorrectal - 2015

Rev. colomb. gastroenterol; 30 (supl.1), 2015
Objetivo: desarrollar una guía de práctica clínica con la evidencia más reciente para la tamización de cáncer de colon y recto en población asintomática de riesgo promedio, dirigida a pacientes, personal asistencial, administrativo y entes gubernamentales de cualquier servicio de atención en Col...

Bladder cancer: diagnosis and management

This guideline covers diagnosing and managing bladder cancer in people 18 and above referred from primary care with suspected bladder cancer, and those with newly diagnosed or recurrent bladder (urothelial carcinoma, adenocarcinoma, squamous-cell carcinoma or small-cell carcinoma) or urethral cancer....